ArticleAnnals of translational medicine2017

Cardiovascular outcome studies with glucagon-like peptide 1 receptor agonists-what will REWIND add?

Keith C Ferdinand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.